We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

223 hedge funds and large institutions have $6.51B invested in Vaxcyte in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more call options, than puts

Call options by funds: $9.9M | Put options by funds: $2.94M

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

26% more capital invested

Capital invested by funds: $5.17B → $6.51B (+$1.34B)

25% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 69

10% more funds holding

Funds holding: 202 → 223 (+21)

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

0.88% more ownership

Funds ownership: 108.03% → 108.91% (+0.88%)

Holders
223
Holders Change
+21
Holders Change %
+10.4%
% of All Funds
3.25%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.2%
New
37
Increased
86
Reduced
69
Closed
16
Calls
$9.9M
Puts
$2.94M
Net Calls
+$6.96M
Net Calls Change
+$6.35M

Top Buyers

1
BlackRock
BlackRock
New York
+$60M
2
Morgan Stanley
Morgan Stanley
New York
+$34.5M
3
DGM
Darwin Global Management
Jersey
+$30.1M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$23.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20M

Top Sellers

1
MVM
Medicxi Ventures Management
Jersey
-$53.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$32.3M
3
FAM
Fred Alger Management
New York
-$22M
4
NIP
Nicholas Investment Partners
California
-$18.1M
5
B
Braidwell
Connecticut
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
OLVIG
201
Oliver Lagore Vanvalin Investment Group
Michigan
$17.8K +$6.39K +123 +76%
SWS
202
SYSTM Wealth Solutions
Illinois
$17K +$14.1K +271 New
C
203
Covestor
United Kingdom
$13K – – –
EWA
204
EverSource Wealth Advisors
Alabama
$12.2K +$8.52K +164 +547%
BTI
205
Blue Trust Inc
Georgia
$8K – – –
ACM
206
ADAR1 Capital Management
Texas
$6.28K +$5.19K +100 New
FFA
207
Farther Finance Advisors
California
$4.21K +$3.12K +60 +857%
Mitsubishi UFJ Asset Management
208
Mitsubishi UFJ Asset Management
Japan
$3.87K – – –
BIA
209
Bell Investment Advisors
California
$3.83K +$104 +2 +3%
WTA
210
Washington Trust Advisors
Massachusetts
$3.83K +$1.51K +29 +91%
PS
211
Principal Securities
Iowa
$3.27K +$2.7K +52 New
GI
212
GAMMA Investing
California
$3.21K +$2.34K +45 New
AWM
213
Able Wealth Management
New Jersey
$2.89K +$2.39K +46 New
BWM
214
Baystate Wealth Management
Massachusetts
$2.51K +$2.08K +40 New
NA
215
NewEdge Advisors
Louisiana
$1.82K +$1.51K +29 New
AF
216
Allworth Financial
California
$1.7K -$104 -2 -7%
BAM
217
Bellevue Asset Management
Washington
$1.44K +$1.2K +23 New
FFO
218
Fortitude Family Office
Arizona
$1.07K +$883 +17 New
PWMG
219
Private Wealth Management Group
New Jersey
$1K +$831 +16 New
Carson Wealth (CWM LLC)
220
Carson Wealth (CWM LLC)
Nebraska
$1K -$1.04K -20 -51%
IFAM
221
Institutional & Family Asset Management
Colorado
$816 – – –
GRP
222
Global Retirement Partners
California
$803 – – –
CPG
223
Cornerstone Planning Group
New Jersey
$63 – – –
MVM
224
Medicxi Ventures Management
Jersey
– -$53.5M -1,049,893 Closed
IC
225
Ikarian Capital
Texas
– -$7.26M -142,417 Closed
6 7 8
9
10

PCVX Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2023, worth a combined $6.51B — up 26% from $5.17B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCVX positions and 16 closed out — a net gain of 21 holders — while 86 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $60M. The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $53.5M sold.

  • 223 institutional investors held Vaxcyte (PCVX) as of Q4 2023, up from 202 in Q3 2023.
  • Funds reported $6.51B of Vaxcyte stock for Q4 2023, up 26% quarter-over-quarter.
  • 37 funds opened new Vaxcyte positions in Q4 2023 and 16 closed out, a net change of +21 holders.
  • The largest Vaxcyte buyer in Q4 2023 was BlackRock, an estimated $60M added.
  • The largest Vaxcyte seller in Q4 2023 was Medicxi Ventures Management, an estimated $53.5M sold.

Based on aggregated 13F filings for Q4 2023.